Leishmania mexicana Trypanothione Reductase Inhibitors: Computational and Biological Studies


Por: Matadamas-Martinez, Felix, Hernandez-Campos, Alicia, Tellez-Valencia, Alfredo, Vazquez-Raygoza, Alejandra, Comparan-Alarcon, Sandra, Yepez-Mulia, Lilian, Castillo, Rafael

Publicada: 1 sep 2019
Resumen:
Leishmanicidal drugs have many side effects, and drug resistance to all of them has been documented. Therefore, the development of new drugs and the identification of novel therapeutic targets are urgently needed. Leishmania mexicana trypanothione reductase (LmTR), a NADPH-dependent flavoprotein oxidoreductase important to thiol metabolism, is essential for parasite viability. Its absence in the mammalian host makes this enzyme an attractive target for the development of new anti-Leishmania drugs. Herein, a tridimensional model of LmTR was constructed and the molecular docking of 20 molecules from a ZINC database was performed. Five compounds (ZINC04684558, ZINC09642432, ZINC12151998, ZINC14970552, and ZINC11841871) were selected (docking scores -10.27 kcal/mol to -5.29 kcal/mol and structurally different) and evaluated against recombinant LmTR (rLmTR) and L. mexicana promastigote. Additionally, molecular dynamics simulation of LmTR-selected compound complexes was achieved. The five selected compounds inhibited rLmTR activity in the range of 32.9% to 40.1%. The binding of selected compounds to LmTR involving different hydrogen bonds with distinct residues of the molecule monomers A and B is described. Compound ZINC12151998 (docking score -10.27 kcal/mol) inhibited 32.9% the enzyme activity (100 mu M) and showed the highest leishmanicidal activity (IC50 = 58 mu M) of all the selected compounds. It was more active than glucantime, and although its half-maximal cytotoxicity concentration (CC50 = 53 mu M) was higher than that of the other four compounds, it was less cytotoxic than amphotericin B. Therefore, compound ZINC12151998 provides a promising starting point for a hit-to-lead process in our search for new anti-Leishmania drugs that are more potent and less cytotoxic.

Filiaciones:
Matadamas-Martinez, Felix:
 Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico

 Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Unidad Médica de Alta Especialidad-Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, 06720, Mexico

 Univ Nacl Autonoma Mexico, Fac Quim, Dept Farm, Mexico City 04510, DF, Mexico

Hernandez-Campos, Alicia:
 Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico

 Univ Nacl Autonoma Mexico, Fac Quim, Dept Farm, Mexico City 04510, DF, Mexico

Tellez-Valencia, Alfredo:
 Facultad de Medicina y Nutrición, Universidad Juárez del Estado de Durango, Av. Universidad y Fanny Anitúa S/N, Durango, 34000, Mexico

 Univ Juarez Estado Durango, Fac Med & Nutr, Ave Univ& Fanny Anitua S-N, Durango 34000, CO, Mexico

Vazquez-Raygoza, Alejandra:
 Facultad de Medicina y Nutrición, Universidad Juárez del Estado de Durango, Av. Universidad y Fanny Anitúa S/N, Durango, 34000, Mexico

 Univ Juarez Estado Durango, Fac Med & Nutr, Ave Univ& Fanny Anitua S-N, Durango 34000, CO, Mexico

Comparan-Alarcon, Sandra:
 Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Unidad Médica de Alta Especialidad-Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, 06720, Mexico

 Inst Mexicano Seguro Social, Ctr Med Nacl Siglo XXI, Unidad Med Alta Especialidad Hosp Pediat, Unidad Invest Med Enfermedades Infecciosas & Para, Mexico City 06720, DF, Mexico

Yepez-Mulia, Lilian:
 Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Unidad Médica de Alta Especialidad-Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, 06720, Mexico

 Inst Mexicano Seguro Social, Ctr Med Nacl Siglo XXI, Unidad Med Alta Especialidad Hosp Pediat, Unidad Invest Med Enfermedades Infecciosas & Para, Mexico City 06720, DF, Mexico

Castillo, Rafael:
 Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico

 Univ Nacl Autonoma Mexico, Fac Quim, Dept Farm, Mexico City 04510, DF, Mexico
ISSN: 14203049





Molecules
Editorial
MDPI AG, POSTFACH, CH-4005 BASEL, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 24 Número: 18
Páginas:
WOS Id: 000488830500008
ID de PubMed: 31487860